High-dose intravenous (IV) iron monotherapy has been evaluated for chemotherapy-induced anemia (CIA), but prior studies mainly focused on patients with hemoglobin (Hb) levels around 10 g/dL. This evidence concerns the gene GSTM1 and anemia.